Journal article
Angiotensin converting enzyme 2 and diminazene: role in cardiovascular and blood pressure regulation
E Velkoska, SK Patel, LM Burrell
Current Opinion in Nephrology and Hypertension | LIPPINCOTT WILLIAMS & WILKINS | Published : 2016
Abstract
Purpose of review Angiotensin converting enzyme 2 (ACE2) is an important regulator of the renin-angiotensin system through actions to degrade angiotensin II. Loss of ACE2 can contribute to the development and progression of cardiovascular disease, and experimental studies have highlighted a beneficial role for novel therapeutic approaches that activate or replenish tissue ACE2. This review focuses on experimental studies that have used the off-target effects of the antitrypanosomal agent, diminazene aceturate (DIZE) to activate ACE2. Recent findings In cardiovascular disease, activation of the classical renin-angiotensin system and depletion of ACE2 leads to pathophysiological changes. One a..
View full abstractRelated Projects (1)
Grants
Funding Acknowledgements
Research in the field of ACE2 and diminazene aceturate is supported by grants from National Health and Medical Research Council of Australia (NHMRC), Diabetes Australia and Austin Medical Research Foundation.